Compare Cytokinetics Inc (CYTK) vs Fox Corp Class A (FOXA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Fox Corp Class A — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Fox Corp Class A trades at $62.43 (market cap $24.58B). The key difference: Fox Corp Class A is far larger — about 2.3× Cytokinetics Inc's market cap, and Fox Corp Class A pays a 0.93% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | FOXA | |
|---|---|---|
Market Cap | $10.63B | $24.58B |
Sector | Technology | Media |
52-Week High | $87.26 | $76.11 |
52-Week Low | $34.31 | $48.79 |
Enterprise Value | $10.74B | $27.94B |
Dividend Yield | — | 0.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →
